St. Louis-based Ascension Ventures and Labcorp have invested in a strategic financing round for Cofactor Genomics.
The company’s flagship test, OncoPrism, uses machine learning to analyze tumors and predict how they will respond to immunotherapy drugs.
“We partner with companies that can meaningfully impact care delivery across our health system partners,” said John Kuelper, senior managing director of Ascension Ventures, in a Dec. 15 news release. “Cofactor’s technology has the potential to change how immunotherapy decisions are made for a significant portion of U.S. cancer patients.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
